Empo Health exists to empower diabetic patients and providers to improve care, outcomes and quality of life.

Empo Health addresses diabetic foot ulcers (DFUs) that affect 25% of diabetic patients in their lifetime and lead to 150,000 amputations annually in the US, with healthcare costs exceeding $80 billion per year.

The company offers the FDA-listed Empo Footprint in-home imaging scale and Empo Remote Health Link patient monitoring service, enabling patients, podiatrists, and payors to detect early signs of ulcers and intervene promptly with less invasive and cost-effective treatments.

Founded in 2020 by MIT-and-Stanford-trained engineers, Empo Health is based in the San Francisco Bay Area and is focused on improving patient outcomes through innovative in-home health monitoring.

Empo Health aims to improve patient outcomes for diabetes patients with an in-home health monitoring device that facilitates daily visual self-inspection of feet, providing better information to both patients and clinicians to prevent disability, hospitalization, and amputation.